Key Developments: MAKO Surgical Corp (MAKO.O)
11.22USD
24 May 2013
$-0.07 (-0.62%)
$11.29
$11.27
$11.49
$11.06
442,695
1,050,563
$27.18
$10.00
Latest Key Developments (Source: Significant Developments)
MAKO Surgical Corp Announces Patent Enforcement Actions Against Stanmore Entities
MAKO Surgical Corp announced that it has filed complaints against Stanmore Implants Worldwide, Ltd. of Elstree, United Kingdom and Stanmore Inc. of Plymouth, Massachusetts with the U.S. International Trade Commission, and the U.S. District Courts of the Northern District of California and the District of Massachusetts collectively alleging infringement of three patents by Stanmore. The patents at issue relate to computerized orthopedic surgical devices and software, and the patent infringement actions are directed at Stanmore's computerized orthopedic surgery guidance systems, including Stanmore's Sculptor Robotic Guidance Arm. Full Article
MAKO Surgical Corp Closes Public Offering Of Common Stock
MAKO Surgical Corp announced that it closed its public offering of 3,498,300 shares of its common stock, which includes 456,300 shares issued as a result of the underwriter's exercise of their over-allotment option. The net proceeds to the Company from the offering are approximately $43 million, after deducting underwriting discounts, commissions and estimated offering expenses. Piper Jaffray & Co. acted as the sole manager for the offering. Moelis & Company acted as financial advisor to MAKO. Full Article
MAKO Surgical Corp Prices Public Offering of Common Stock
MAKO Surgical Corp announced the pricing of its previously announced underwritten public offering. Pursuant to the offering, MAKO has sold 3,042,000 shares of its common stock at a public offering price of $13.15 per share. In connection with the offering, MAKO has also granted the underwriter a 30-day option to purchase up to an additional 456,300 shares of common stock to cover over-allotments, if any. Piper Jaffray & Co. acted as the sole manager for the offering. Moelis & Company acted as financial advisor to MAKO. Net proceeds from the sale of the shares after underwriting discounts and commissions and other offering expenses are expected to be approximately $37 million. If the underwriter exercises its over-allotment option in full, net proceeds from the offering will be approximately $43 million. The offering is expected to close on November 19, 2012. MAKO expects to use the net proceeds from the offering for commercialization infrastructure, selling, general and administrative activities, research and development activities and to fund working capital and other general corporate purposes. Full Article
MAKO Surgical Corp Announces Commencement Of Public Offering Of Common Stock
MAKO Surgical Corp announced that it intends to offer shares of its common stock in a public offering. Piper Jaffray & Co. is acting as the sole manager for the offering. MAKO expects to use the net proceeds from the offering for commercialization infrastructure, selling, general and administrative activities, research and development activities and to fund working capital and other general corporate purposes. Full Article
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In Class Action Lawsuit against MAKO Surgical Corp.
Law Offices of Todd M. Garber announced that shareholders of MAKO Surgical Corp. (MAKO or the Company) have until July 9, 2012 to move for lead plaintiff status in the shareholder lawsuit filed in the United States District Court for the Southern District of Florida against MAKO and certain of its executive officers. The lawsuit was filed on behalf of a class (the Class) comprising all purchasers of MAKO common stock between January 9, 2012 and May 7, 2012, inclusive (the Class Period). MAKO offers its RIO Robotic Arm Interactive Orthopedic ("RIO") system and MAKOplasty applications (collectively, the "RIO system"), which enable orthopedic surgeons to treat patient-specific osteoarthritic disease. The Complaint alleges that the Company and certain of its executive officers issued materially false and misleading statements and/or failed to disclose material adverse facts concerning MAKO`s business and financial prospects. Specifically, defendants misrepresented or failed to disclose that: the Company was poised to suffer a larger first-quarter loss due to higher costs and slower sales of its RIO systems; utilization rates were declining for the Company`s RIO systems; the Company`s 2012 outlook, provided at the start of the Class Period, lacked a reasonable basis when made; and, based on the foregoing, defendants` positive statements about the Company or its outlook lacked a reasonable basis. Full Article
Levi & Korsinsky Notifies Investors With Losses On Their Investment In MAKO Surgical Corporation Of Class Action Lawsuit And Deadline Of July 9, 2012 To Seek Lead Plaintiff Position
Levi & Korsinsky announced that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of investors who purchased MAKO Surgical Corporation common stock between January 9, 2012 and May 7, 2012. The complaint alleges that defendants misrepresented and/or failed to disclose: (a) that the Company was experiencing higher costs and slower sales of its RIO systems, and thus was set to suffer a larger first quarter loss; (b) that utilization rates of the Company’s RIO systems were dropping; (c) that the Company’s 2012 Outlook lacked a reasonable basis when made; and (d) that, based on the above, defendants lacked a reasonable basis for their positive statements about the Company and its prospects. Full Article
Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In Class Action Lawsuit Against MAKO Surgical Corp.
Glancy Binkow & Goldberg LLP, representing shareholders of MAKO Surgical Corp., announced that all purchasers of the Company’s common stock between January 9, 2012 and May 7, 2012, inclusive (the Class Period), have until July 9, 2012 to file a motion with the Court to be appointed as Lead Plaintiff. The securities fraud class action lawsuit was filed in the United States District Court for the Southern District of Florida. The Complaint charges MAKO and certain of the Company’s executive officers with violations of federal securities laws. Specifically, the Complaint alleges that the defendants misrepresented or failed to disclose that: (a) the Company was poised to suffer a larger first-quarter loss due to higher costs and slower sales of its RIO systems; (b) utilization rates were declining for the Company’s RIO systems; (c) the Company’s 2012 outlook, provided at the start of the Class Period, lacked a reasonable basis when made; and (d), based on the foregoing, defendants’ positive statements about the Company or its outlook lacked a reasonable basis. Full Article
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against MAKO Surgical Corp.
Law Offices of Todd M. Garber announced that a class action lawsuit has been filed in the United States District Court for the Southern District of Florida on behalf of a class (the Class) comprising all persons or entities who purchased or otherwise acquired the common stock of MAKO Surgical Corp. between January 9, 2012 and May 7, 2012, inclusive (the Class Period), seeking to pursue remedies under the Securities Exchange Act of 1934. The Complaint alleges that the Company and certain of its executive officers issued materially false and misleading statements and/or failed to disclose material adverse facts concerning MAKO’s business and financial prospects. Specifically, defendants misrepresented or failed to disclose that: (a) the Company was poised to suffer a larger first-quarter loss due to higher costs and slower sales of its RIO systems; (b) utilization rates were declining for the Company’s RIO systems; (c) the Company’s 2012 outlook, provided at the start of the Class Period, lacked a reasonable basis when made; and (d), based on the foregoing, defendants’ positive statements about the Company or its outlook lacked a reasonable basis. Full Article
Saxena White P.A. Files Securities Fraud Class Action Against MAKO Surgical Corp
Saxena White P.A. announced that it has filed a class action lawsuit in the United States District Court for the Southern District of Florida on behalf of all investors who purchased MAKO Surgical Corp. common stock during the period between January 9, 2012 and May 7, 2012. The Complaint alleges that the defendants misrepresented or failed to disclose that: the Company was poised to suffer a larger first-quarter loss due to higher costs and slower sales of its RIO systems; utilization rates were declining for the Company's RIO systems; the Company's 2012 outlook, provided at the start of the Class Period, lacked a reasonable basis when made; and, based on the foregoing, defendants' positive statements about the Company or its outlook lacked a reasonable basis. Full Article
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In Class Action Lawsuit Against MAKO Surgical Corp.
Law Offices of Howard G. Smith announced that all purchasers of the common stock of MAKO Surgical Corp. between January 9, 2012 and May 7, 2012, inclusive (the Class Period), have until July 9, 2012, to move the Court to serve as Lead Plaintiff in the securities fraud class action lawsuit filed in the United States District Court for the Southern District of Florida. The Complaint alleges that the Company and certain of its executive officers misrepresented or failed to disclose that: (a) the Company was poised to suffer a larger first-quarter loss as it was experiencing higher costs and slower sales of its RIO systems; (b) utilization rates were declining for the Company’s RIO systems; (c) the Company provided 2012 revenue outlook at the start of the Class Period that lacked a reasonable basis when made; and (d) based on the foregoing, defendants positive statements about the Company or its outlook lacked a reasonable basis. Full Article
BRIEF-MAKO Surgical up in extended trade after Q4 results
NEW YORK, Feb 26 - MAKO Surgical Corp : * Up 4.6 percent to $11.50 in extended trade after Q4 results
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
